Susan ALTSCHULLER - 15 May 2023 Form 3 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role: Chief Financial Officer
Signature: /s/ Mark Bodenrader, as Attorney-in-Fact
Issuer symbol: CERE
Transactions as of: 15 May 2023
Transactions value $: $0
Form type: 3
Filing time: 19 May 2023, 16:15:13 UTC
Previous filing: 27 Dec 2022
Next filing: 05 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney